Key characteristics of the tissue microenvironment are fundamentally changed in cancer, yielding the tumour microenvironment. Some of these changes are tumour cell-driven and result in tumour-promoting changes in the microenvironment, whilst others are systemically driven, resulting in tumour-suppressive changes in the microenvironment. Interaction with the tumour microenvironment is therefore fundamental to the ability of cancers to grow and spread around the body. Blocking the ability of cancers to exploit their microenvironments has potential to reveal novel therapy approaches against invasive and metastatic cancers.
The Rho-ROCK signalling pathway is known to regulate the contractility of the cellular actomyosin cytoskeleton to promote tumour cell migration and invasion. Less well-understood is its role in modifying the tissue microenvironment. We have discovered that activation of the ROCK kinase causes over-production and abnormal remodelling of collagen and other extracellular matrix (ECM) components in many tissues, and establishes an immune milieu that interferes with systemic anti-cancer mechanisms. The resulting increase in tissue density disrupts normal tissue homeostasis, enhanced cancer cell proliferation and promotes tumour progression, whilst the impaired ability of the immune system to target cancer cells permits their survival. Using Rho-ROCK signalling as a tool, we research the biochemical and biomechanical mechanisms by which microenvironments are established and maintained in normal tissue homeostasis, and hijacked in cancer.